CompoAtlas

Macérat concentré de bourgeons frais de myrtillier

Food supplement declared in France, decision dated 23 July 2026

Macérat concentré de bourgeons frais de myrtillier (TerreEsSens) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Vaccinium myrtillus 0.5 g per day. None of the rules we check flags an issue with its declared composition.

Brand
TerreEsSens
Food business operator placing the product on the market
Sophie Vincent
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Dropper
Daily dose
0.5 ml
Directions for use
5 à 15 gouttes maximum par jour dans un peu d'eau, en dehors des repas pendant 21 jours. fare une pause de 1 semaine et renouveler
Intended populations
General population, Men and women aged 18 and over, People over 60
Not recommended (according to the manufacturer)
Breastfeeding women, History of breast cancer, Taking away from meals, Children (under 12), Pregnant women
Objectives stated by the manufacturer (these are not authorised claims)
Detox / Drainage, Eye / Vision

Declaration 371514, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Vaccinium myrtillus L.Jeune pousseAutre macérât0.5 g

Additives

E422

Other ingredients

Alcool, eau

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vaccinium myrtillus L.
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : TerreEsSens

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Macérat concentré de bourgeons frais de myrtillier (TerreEsSens): composition and regulation”, https://compoatlas.com/en/supplements/products/371514-macerat-concentre-de-bourgeons-frais-de-myrtillier, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line